Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the metformin in gestational diabetes (MiG) trial: responses to maternal metformin versus insulin treatment.

Diabetes Care · 2013 · PMC3579335 · PMID 23048188

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

a nonsignificant trendP = 0.08so close (0.05 < p ≤ 0.1)

For infants <10th centile ( Supplementary Table 3 ), there was a nonsignificant trend in relationship with C-peptide for women randomized to metformin (odds ratio [OR] 0.22 [95% CI 0.04–1.20], n = 64, P = 0.08) and triglycerides in women randomized to insulin (0.56 [0.29–1.09], n = 187, P = 0.09).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.